BALAXI PHARMA

BALAXI · NSE

19.71

-0.62 (-3.05%)

as of 29 Oct 2026 close

Open

20.60

High

20.60

Low

19.16

Prev close

20.33

52w high

43.85

04 Nov 2025

52w low

15.20

27 Mar 2026

VWAP

19.81

Delivery %

71.2%

of volume

Volume 31,016 · turnover ₹6.15 L · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 09 Oct 2017

ISIN: INE618N01022
Series: EQ
Listed on NSE: 30 Nov 2015
Face value: ₹2
F&O: No

Formerly ANANDAMRUB (until 27 Sept 2017). Earlier name: Balaxi Ventures Limited (until 20 Oct 2020).

Source: NSE equity master · as of 30 Oct 2026

Daily · NSE EOD

Moving averages & momentum · as of 29 Oct 2026 close

SMA 20	21.65	below by -8.97%
SMA 50	22.62	below by -12.86%
SMA 200	23.27	below by -15.30%
RSI 14	27.8	below 30
ATR 14	1.24	6.32% of price / day

How these are computed

SMA n = mean of last n daily closes. RSI 14 = Wilder smoothing of average gains/losses over 14 days. ATR 14 = Wilder average of true range (max of high−low, |high−prev close|, |low−prev close|). All from NSE end-of-day candles; nothing intraday.

52-week position · as of 29 Oct 2026 close

15.20 27 Mar 202616% of range43.85 04 Nov 2025

Returns · close to close

-6.14%

-11.97%

-18.35%

-25.73%

-54.07%

Corporate actions · latest 3 · NSE

30 May 2024	Price adjustment	×4.893	Derived from the ex-date price gap
30 May 2024	Split	×5	Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
01 Jul 2022	Dividend	₹0.5/share	Annual General Meeting/Dividend - Rs 0.50 Per Share

Ex-dates and subjects from NSE's corporate-actions feed; price-adjustment factors checked against the exchange's own prices. Charts use the adjusted series by default.